These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 22037934

  • 1. Impact of FDG-PET/CT in the management of lymphoma.
    Baba S, Abe K, Isoda T, Maruoka Y, Sasaki M, Honda H.
    Ann Nucl Med; 2011 Dec; 25(10):701-16. PubMed ID: 22037934
    [Abstract] [Full Text] [Related]

  • 2. PET/CT for therapy response assessment in lymphoma.
    Hutchings M, Barrington SF.
    J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
    [Abstract] [Full Text] [Related]

  • 3. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
    Kasamon YL, Jones RJ, Wahl RL.
    J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
    [Abstract] [Full Text] [Related]

  • 4. Role of functional imaging in the management of lymphoma.
    Cheson BD.
    J Clin Oncol; 2011 May 10; 29(14):1844-54. PubMed ID: 21482982
    [Abstract] [Full Text] [Related]

  • 5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 10; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Magnetic resonance imaging of malignant lymphoma.
    Vermoolen MA, Kersten MJ, Fijnheer R, van Leeuwen MS, Kwee TC, Nievelstein RA.
    Expert Rev Hematol; 2011 Apr 10; 4(2):161-71. PubMed ID: 21495926
    [Abstract] [Full Text] [Related]

  • 11. FDG-PET in the clinical management of Hodgkin lymphoma.
    Hutchings M, Eigtved AI, Specht L.
    Crit Rev Oncol Hematol; 2004 Oct 10; 52(1):19-32. PubMed ID: 15363464
    [Abstract] [Full Text] [Related]

  • 12. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H, Fury M, Lee N, Kraus D.
    J Nucl Med; 2009 May 10; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
    Belakhlef A, Jani C, Church C, Fraser R, Lakhanpal S.
    Clin Nucl Med; 2008 Apr 10; 33(4):271-2. PubMed ID: 18356666
    [Abstract] [Full Text] [Related]

  • 15. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U, Even-Sapir E.
    Semin Nucl Med; 2007 May 10; 37(3):206-22. PubMed ID: 17418153
    [Abstract] [Full Text] [Related]

  • 16. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec 10; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
    Krause BJ, Herrmann K, Wieder H, zum Büschenfelde CM.
    J Nucl Med; 2009 May 10; 50 Suppl 1():89S-96S. PubMed ID: 19380406
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.
    Pediatr Blood Cancer; 2007 Dec 10; 49(7):901-5. PubMed ID: 17252575
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.